Sign in

CIK 0001070081

  • Large accelerated filer

PTC THERAPEUTICS, INC.

Sign in to watch
Ticker
PTCT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043416587
Phone
+1 908-222-7000
Business address
500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
Former names
PTC THERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,548,017
in 9 filings, $7.5M under 10b5-1 plans

Net −$7,548,017. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-01-09 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −2,065 $29.01 $60K 44,547
2024-01-09 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −5,443 $29.01 $158K 160,475
2024-01-09 Golden Lee Scott CHIEF MEDICAL OFFICER Sale 10b5-1 −1,225 $29.01 $36K 37,914
2024-01-09 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −1,938 $29.01 $56K 71,983
2024-01-09 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sale 10b5-1 −1,521 $29.01 $44K 61,820
2024-01-09 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sale 10b5-1 −100 $29.01 $3K 3,734
2024-01-08 Utter Christine Marie SVP, FINANCE & CAO Sale 10b5-1 −1,188 $28.64 $34K 37,499
2024-01-08 SCHMERTZLER MICHAEL Director Sale 10b5-1 −1,500 $27.81 $42K 115,266
2024-01-08 Pauwels Eric CHIEF BUSINESS OFFICER Sale 10b5-1 −1,569 $28.64 $45K 46,612
2024-01-08 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −2,237 $28.64 $64K 165,918
2024-01-08 Golden Lee Scott CHIEF MEDICAL OFFICER Sale 10b5-1 −775 $28.64 $22K 39,139
2024-01-08 Boulding Mark Elliott EXEC. VP AND CLO Sale 10b5-1 −1,457 $28.64 $42K 73,921
2024-01-08 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sale 10b5-1 −1,236 $28.64 $35K 63,341
2024-01-08 Almstead Neil Gregory CHIEF TECHNICAL OPS OFFICER Sale 10b5-1 −53 $28.64 $2K 3,834
2024-01-05 Klein Matthew B. CHIEF EXECUTIVE OFFICER Sale 10b5-1 −10,107 $27.15 $274K 168,155
2023-12-28 Klein Matthew B. CHIEF EXECUTIVE OFFICER Grant or award +75,000 177,961
2023-12-12 Gravier Pierre CHIEF FINANCIAL OFFICER Purchase +7,700 $25.81 $199K 33,700
2023-09-06 Young Alethia Director Option exercise +7,000 $27.85 $195K 16,067
2023-09-06 Young Alethia Director Sale −7,000 $39.90 $279K 9,067
2023-09-06 Young Alethia Director Option exercise +4,666 $27.85 $130K 13,733

Page 36 of 41 · 804 trades